In today’s business landscape, the adoption of artificial intelligence (AI) is growing faster than ever before. Generative AI (GenAI) is no longer just an experimental tool — it has become a key driver of growth, productivity, and innovation in the workplace. According to a recent ISG survey of G2000 companies in North America and Europe, over 65% of organizations are already using GenAI, and that number is expected to rise to 80% by 2026.
However, as AI becomes an integral part of every team and process, many organizations are facing an invisible obstacle — the so-called “AI tax.” This tax doesn’t come from the government but from a range of hidden costs, technical issues, and inefficiencies that arise when multiple disconnected AI tools are used. Managing various licenses, duplicated functionalities, and fragmented data often leads to higher expenses and more complex maintenance instead of innovation.
The solution lies in centralized AI platforms. These platforms unify all AI functionalities — from security and data management to integrations — in one place. This allows organizations to reduce costs, increase efficiency, and gain better control over the development and deployment of AI solutions.
The report The State of AI at Work in 2025 by Glean provides detailed insights into how leading organizations are avoiding the “AI tax” and building unified, smarter AI ecosystems. In the report, you’ll learn:
- Where organizations are investing in AI in 2025.
- How the hidden “AI tax” emerges from fragmented tools.
- How centralized AI platforms reduce costs, strengthen security, and drive sustainable growth.
Read the full article here.
In brief: Tech World Highlights
- OpenAI plans to build a massive 1-gigawatt data center and open an office in India as part of its global “Stargate” infrastructure initiative, Bloomberg reports.
- California-based startup Flip, which reached a $1 billion valuation in 2024 thanks to its TikTok-like shopping and review app, has now shut down operations.
- California biotech firm Exelixis, specializing in anti-cancer therapies, is laying off 130 employees, consolidating operations, and closing its Pennsylvania facility.
- Novo Nordisk secured global rights to Replicate Bioscience’s self-replicating RNA technology in a deal worth up to $550 million, targeting new therapies for obesity and diabetes.
- Finland launched the world’s largest industrial sand battery in the city of Pornainen, aiming to cut local heating emissions by 70%.
AI Trending Tools:
- Genspark AI Developer – Create anything without coding knowledge.
- GPT-5 – New personality update with a “warmer” and “friendlier” tone.
- Kaggle Game Arena – A benchmark test to evaluate LLMs in evolving strategy games.
